NEW YORK, June 27, 2017 -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Axiom Holdings, Inc. ("Axiom" or the "Company") (OTCMKT:AIOM) securities and certain of its officers, on behalf of a class who purchased Axiom securities between October 14, 2016 and June 19 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/aiom.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.
On October 10, 2016, Axiom Holdings, Inc. entered a Share Exchange Agreement (the “Agreement”) with CJC Holdings, Ltd. (and its subsidiaries, “CJC”), a Hong Kong corporation, and the two shareholders of CJC, Hu Dengyang and Yang Chuan (collectively, the “CJC Shareholders”). CJC and its subsidiaries run multiple hydropower electric generation stations and operate two hotels in China.
Pursuant to the Agreement, Axiom was to procure all of CJC’s issued and outstanding shares from the CJC Shareholders in exchange for the issuance of 200,000,000 shares of Axiom common stock.
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Axiom, lacked control over the merger process sufficient to ensure that the Agreement with CJC would be completed; (2) as a result, the Agreement with CJC was never completed; (3) Axiom’s issuance of shares to the CJC Shareholders was thus improper; and (4) consequently, Axiom’s public statements were materially false and misleading at all relevant times.
On June 19, 2017, Axiom revealed that it had identified discrepancies connected to prior news releases following a subpoena from the U.S. Securities and Exchange Commission. Specifically, Axiom disclosed: (1) issues relating to the propriety of Axiom’s December 2016 share exchange with CJC Holdings, Ltd. (“CJC”), under which Axiom acquired all CJC’s outstanding shares; and (2) that the purported Chief Executive Officer of CJC, who signed the share exchange agreement in December 2016, had resigned from that role a month earlier. The next day, Axiom advised investors that “it now appears the merger was never completed” and that it would rescind the shares that were issued to the CJC Shareholders in connection with the merger. Following these revelations, Axiom stock dropped $0.44 per share, or 37.93% over two trading days, to close at $0.72 on June 20, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/aiom or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Axiom’s you have until August 21, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


First Western Ship Transits Strait of Hormuz Since Iran War Began
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Apple Turns 50: From Garage Startup to AI Crossroads
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Britain Courts Anthropic Amid US Defense Department Dispute 



